MapLight Therapeutics (MPLT) Change in Account Payables (2024 - 2025)
MapLight Therapeutics (MPLT) posted Change in Account Payables of $893000.0 for Q4 2025, up 668.79% sequentially from -$157000.0 in Q4 2024, and up 668.79% YoY from $116156.6 in Q4 2024.
Powered by 
Analysis
MapLight Therapeutics (MPLT) Change in Account Payables (2024 - 2025) Analysis & Trends
MapLight Therapeutics has reported Change in Account Payables for 2 years, with the latest figure at $893000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | - |
| 10 | MapLight Therapeutics | 635.58 Mn | 635.58 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 893,000.00 |
| Sep 30, 2025 | 301,000.00 |
| Dec 31, 2024 | -157,000.00 |